Barnett Renee Eva's most recent trade in Immunovant Inc was a trade of 2,993 Common Stock done at an average price of $14.9 . Disclosure was reported to the exchange on April 16, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Immunovant Inc | Eva Renee Barnett | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 14.89 per share. | 16 Apr 2025 | 2,993 | 396,774 (0%) | 0% | 14.9 | 44,566 | Common Stock |
| Immunovant Inc | Eva Renee Barnett | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 12.99 per share. | 09 Apr 2025 | 7,013 | 403,817 (0%) | 0% | 13.0 | 91,099 | Common Stock |
| Immunovant Inc | Eva Renee Barnett | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 12.99 per share. | 09 Apr 2025 | 4,050 | 399,767 (0%) | 0% | 13.0 | 52,610 | Common Stock |
| Immunovant Inc | Eva Renee Barnett | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2025 | 125,180 | 125,180 | - | - | Stock Option (right to buy) | |
| Immunovant Inc | Eva Renee Barnett | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2025 | 88,878 | 410,830 (0%) | 0% | 0 | Common Stock | |
| Immunovant Inc | Eva Renee Barnett | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 20.86 per share. | 19 Feb 2025 | 2,814 | 321,952 (0%) | 0% | 20.9 | 58,700 | Common Stock |
| Immunovant Inc | Eva Renee Barnett | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 23.81 per share. | 15 Jan 2025 | 2,189 | 324,875 (0%) | 0% | 23.8 | 52,120 | Common Stock |
| Immunovant Inc | Eva Renee Barnett | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 24.19 per share. | 15 Jan 2025 | 109 | 324,766 (0%) | 0% | 24.2 | 2,637 | Common Stock |
| Immunovant Inc | Eva Renee Barnett | Chief Financial Officer | 20 Nov 2024 | 4,174 | 331,169 (0%) | 0% | 25.4 | 106,228 | Common Stock | |
| Immunovant Inc | Eva Renee Barnett | Chief Financial Officer | 16 Oct 2024 | 3,271 | 335,343 (0%) | 0% | 28.8 | 94,172 | Common Stock | |
| Immunovant Inc | Eva Renee Barnett | Chief Financial Officer | 09 Oct 2024 | 5,162 | 338,614 (0%) | 0% | 29.6 | 152,589 | Common Stock | |
| Immunovant Inc | Eva Renee Barnett | Chief Financial Officer | 21 Aug 2024 | 3,619 | 343,925 (0%) | 0% | 31.8 | 115,229 | Common Stock | |
| Immunovant Inc | Eva Renee Barnett | Chief Financial Officer | 21 Aug 2024 | 149 | 343,776 (0%) | 0% | 32.3 | 4,816 | Common Stock | |
| Immunovant Inc | Eva Renee Barnett | Chief Financial Officer | 17 Jul 2024 | 2,939 | 347,728 (0%) | 0% | 29.6 | 87,112 | Common Stock | |
| Immunovant Inc | Eva Renee Barnett | Chief Financial Officer | 17 Jul 2024 | 184 | 347,544 (0%) | 0% | 30.5 | 5,621 | Common Stock | |
| Immunovant Inc | Eva Renee Barnett | Chief Financial Officer | 09 Jul 2024 | 4,747 | 350,667 (0%) | 0% | 28.1 | 133,201 | Common Stock | |
| Immunovant Inc | Eva Renee Barnett | Chief Financial Officer | 22 May 2024 | 4,042 | 355,414 (0%) | 0% | 29.6 | 119,845 | Common Stock | |
| Immunovant Inc | Eva Renee Barnett | Chief Financial Officer | 17 Apr 2024 | 9,479 | 362,230 (0%) | 0% | 28.8 | 272,995 | Common Stock | |
| Immunovant Inc | Eva Renee Barnett | Chief Financial Officer | 17 Apr 2024 | 2,774 | 359,456 (0%) | 0% | 29.9 | 83,054 | Common Stock | |
| Immunovant Inc | Eva Renee Barnett | Chief Financial Officer | 09 Apr 2024 | 3,689 | 371,709 (0%) | 0% | 31.2 | 115,023 | Common Stock | |
| Immunovant Inc | Eva Renee Barnett | Chief Financial Officer | 02 Apr 2024 | 68,723 | 68,723 | - | - | Stock Option (right to buy) | ||
| Immunovant Inc | Eva Renee Barnett | Chief Financial Officer | 02 Apr 2024 | 54,978 | 375,398 (0%) | 0% | 0 | Common Stock | ||
| Immunovant Inc | Renee Eva Barnett | Chief Financial Officer | 22 Feb 2024 | 2,930 | 320,420 (0%) | 0% | 36.2 | 105,920 | Common Stock | |
| Immunovant Inc | Barnett Renee Eva | Chief Financial Officer | 11 Jan 2024 | 2,681 | 324,184 (0%) | 0% | 41.6 | 111,637 | Common Stock | |
| Immunovant Inc | Renee Eva Barnett | Chief Financial Officer | 11 Jan 2024 | 834 | 323,350 (0%) | 0% | 42.4 | 35,387 | Common Stock | |
| Immunovant Inc | Eva Renee Barnett | Chief Financial Officer | 24 Aug 2023 | 14,385 | 335,478 (0%) | 0% | 20.3 | 292,016 | Common Stock | |
| Immunovant Inc | Eva Renee Barnett | Chief Financial Officer | 24 Aug 2023 | 1 | 335,477 (0%) | 0% | 21 | 21 | Common Stock | |
| Immunovant Inc | Eva Renee Barnett | Chief Financial Officer | 19 Jul 2023 | 2,725 | 349,863 (0%) | 0% | 24.9 | 67,962 | Common Stock | |
| Immunovant Inc | Eva Renee Barnett | Chief Financial Officer | 18 Apr 2023 | 3,423 | 352,588 (0%) | 0% | 15.3 | 52,269 | Common Stock | |
| Immunovant Inc | Eva Renee Barnett | Chief Financial Officer | 12 Apr 2023 | 113,821 | 113,821 | - | - | Stock Option (right to buy) | ||
| Immunovant Inc | Eva Renee Barnett | Chief Financial Officer | 12 Apr 2023 | 87,664 | 356,011 (0%) | 0% | 0 | Common Stock | ||
| Immunovant Inc | Eva Renee Barnett | Chief Financial Officer | 11 Jan 2023 | 4,499 | 268,347 (0%) | 0% | 16.7 | 75,358 | Common Stock | |
| Immunovant Inc | Eva Renee Barnett | Chief Financial Officer | 11 Jan 2023 | 11 | 272,846 (0%) | 0% | 15.2 | 167 | Common Stock | |
| Immunovant Inc | Eva Renee Barnett | Chief Financial Officer | 11 Oct 2022 | 12,500 | 272,857 (0%) | 0% | 9.4 | 118,000 | Common Stock | |
| Immunovant Inc | Eva Renee Barnett | Chief Financial Officer | 17 Aug 2022 | 169,648 | 169,648 | - | - | Stock Option (right to buy) | ||
| Immunovant Inc | Eva Renee Barnett | Chief Financial Officer | 17 Aug 2022 | 112,816 | 285,357 (0%) | 0% | 0 | Common Stock | ||
| Immunovant Inc | Eva Renee Barnett | Chief Financial Officer | 07 Jan 2022 | 29,959 | 172,541 (0%) | 0% | 7.3 | 217,203 | Common Stock |